Joint statement offers new recommendations for treating cardiovascular conditions
the ONA take:
A new scientific statement issued jointly by the American Heart Association, American College of Cardiology, and American Society of Hypertension addresses treatment goals for patients with high blood pressure who also have vascular diseases.
The statement acknowledges that a target blood pressure of less than 140/90 mm Hg is reasonable to reduce the risk of heart attacks and strokes in the general population, a lower target of less than 130/80 mm Hg may be appropriate for some patients with heart disease who have already experienced a stroke, heart attack, or mini-stroke (transient ischemic attack [TIA]).
Additional recommendations and contraindications include which antihypertensives to use in patients with various types of heart disease. The statement also recommends lowering blood pressure slowly in patients with coronary artery blockages.
Furthermore, clinicians should not strive to lower the diastolic number to less than 60 mm Hg, especially in patients older than 60 years.
These recommendations also reiterate the importance of modifying other risk factors, including abdominal obesity, abnormal cholesterol, diabetes, and smoking.
New statement addresses treatment goals for patients with high blood pressure who also have vascular diseases.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|